The Value of Comparative Effectiveness Alliance for Health Reform Congressional Briefing Karen Ignagni America’s Health Insurance Plans April 04, 2008

Why Do We Need an Entity for Comparative Effectiveness Now? Explosion of New Technology Uncertainty About Safety and Effectiveness Growing Concern About Impact of Cost of Technology on Families, Employers and Government Need for Organized, Robust and Reliable Assessment

What Problems Can Be Addressed? Need for “Trusted Source” of Objective Information Insufficient Information in Practitioners’ Hands Insufficient Information in Consumer and Purchasers’ Hands Inability to Transition to More Effective and Efficient Practice

How Should Comparative Effectiveness Be Done? Form Independent Body Public/Private Entity Ability to Draw Upon Work of Existing Entities Function Set Priorities Commission Studies/Research Validate Results Disseminate Results to Clinicians and Consumers

What is the Value of Comparative Effectiveness? Targets Specific Populations Rewards Effectiveness and Value Builds on Existing Infrastructure Informs Benefit Design

What’s Necessary Beyond Comparative Effectiveness for a National Quality Strategy? Better Funding of Quality Enterprise A Process to Set a National Research Agenda to Identify Gaps in Evidence and Safety An Entity to Coordinate the Dissemination of Clinical Best Practices A Process that is Sufficient to Perform Initial Review of Devices Uniform Performance Measurement, Data Aggregation and Dissemination Malpractice Reform